UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-06, Vol.382 (23), p.2197-2206

2020

Volltextzugriff (PDF)

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design

BMJ open, 2021-08, Vol.11 (8), p.e046588-e046588

2021

Volltextzugriff (PDF)

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study

International journal of urology, 2021-07, Vol.28 (7), p.765-773

2021

Volltextzugriff (PDF)

Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction : The REversal of ventricular remodeling with toprol-XL (REVERT) trial

Circulation (New York, N.Y.), 2007-07, Vol.116 (1), p.49-56

2007

Volltextzugriff (PDF)

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: A post hoc analysis of eight double blind prospective studies

The American journal of gastroenterology, 2002-12, Vol.97 (12), p.2992-2997

2002

Volltextzugriff (PDF)

Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Diabetes care, 2014-03, Vol.37 (3), p.740-750

2014

Volltextzugriff (PDF)

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance : Results of Three US multicenter, double-blind trials

The American journal of gastroenterology, 2000-12, Vol.95 (12), p.3393-3398

2000

Volltextzugriff (PDF)

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

The journal of clinical endocrinology and metabolism, 2012-03, Vol.97 (3), p.1020-1031

2012

Volltextzugriff (PDF)

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Journal of clinical oncology, 2019-11, Vol.37 (32), p.2974-2986

2019

Volltextzugriff (PDF)

Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience

The Journal of pediatrics, 2007-02, Vol.150 (2), p.134-139.e1

2007

Volltextzugriff (PDF)

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies

The American journal of gastroenterology, 2002-12, Vol.97 (12), p.2992-2997

2002

Volltextzugriff (PDF)

Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years

The journal of clinical hypertension (Greenwich, Conn.), 2008-10, Vol.10 (10), p.743-750

2008

Volltextzugriff (PDF)

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial

Annals of internal medicine, 2012-03, Vol.156 (6), p.405

2012

Volltextzugriff (PDF)

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

The New England journal of medicine, 2023-10, Vol.389 (16), p.1453-1465

2023

Volltextzugriff (PDF)

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Diabetes care, 2015-07, Vol.38 (7), p.1218-1227

2015

Volltextzugriff (PDF)

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin

Journal of diabetes and its complications, 2013-09, Vol.27 (5), p.479-484

2013

Volltextzugriff (PDF)

Urinary tract infections in patients with diabetes treated with dapagliflozin

Journal of diabetes and its complications, 2013-09, Vol.27 (5), p.473-478

2013

Volltextzugriff (PDF)

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension

Journal of the American Geriatrics Society (JAGS), 2014-07, Vol.62 (7), p.1252-1262

2014

Volltextzugriff (PDF)

Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial

The Journal of urology, 2023-03, Vol.209 (3), p.532-539

2023

Volltextzugriff (PDF)

Prevalence of DNA damage repair (DDR) alterations in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving enzalutamide (ENZA) or placebo (PBO) plus androgen deprivation therapy (ADT): ARCHES post hoc analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5074-5074

2022

Volltextzugriff (PDF)

The association of germline HSD3B1 genotype with outcomes in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) with or without enzalutamide (ENZA) [ARCHES]

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5022-5022

2022

Volltextzugriff (PDF)

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

The American journal of gastroenterology, 2000, Vol.95 (12), p.3393-3398

2000

Volltextzugriff (PDF)

Metoprolol succinate extended release/hydrochlorothiazide combination tablets

Vascular health and risk management, 2007, Vol.3 (3), p.279-288

2007

Volltextzugriff (PDF)

Association between urinary, bowel, and hormonal treatment-related symptoms and clinical outcomes in nonmetastatic castration-resistant prostate cancer (nmCRPC): PROSPER study

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.233-233

2019

Volltextzugriff (PDF)

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER

European journal of cancer (1990), 2022-07, Vol.170, p.285-295

2022

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(172)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

Englisch
(185)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(121)
Humans
(86)
Female
(52)
Male
(49)
Public, Environmental & Occupational Health
(42)
Middle Aged
(38)
Aged
(31)
Environmental Sciences & Ecology
(27)
Environmental Sciences
(25)
Adult
(23)
Mental Health
(23)
Oncology
(22)
Adolescent
(20)
Pandemics
(20)
Treatment Outcome
(19)
Biological And Medical Sciences
(17)
Covid-19
(17)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study

Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction : The REversal of ventricular remodeling with toprol-XL (REVERT) trial

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: A post hoc analysis of eight double blind prospective studies

Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance : Results of Three US multicenter, double-blind trials

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies

Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin

Urinary tract infections in patients with diabetes treated with dapagliflozin

Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension

Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial

Prevalence of DNA damage repair (DDR) alterations in patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving enzalutamide (ENZA) or placebo (PBO) plus androgen deprivation therapy (ADT): ARCHES post hoc analysis

The association of germline HSD3B1 genotype with outcomes in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) with or without enzalutamide (ENZA) [ARCHES]

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

Metoprolol succinate extended release/hydrochlorothiazide combination tablets

Association between urinary, bowel, and hormonal treatment-related symptoms and clinical outcomes in nonmetastatic castration-resistant prostate cancer (nmCRPC): PROSPER study

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER

Suchergebnisse filtern